Expression of the MicroRNA Regulators Drosha, Dicer and Ago2 in Non-small Cell Lung Carcinomas

Overview

Journal Cell Oncol (Dordr)

Publisher Springer

Date 2015 Aug 1

PMID 26227789

Citations 22

Authors

E Prodromaki

A Korpetinou

E Giannopoulou

E Vlotinou

M Chatziathanasiadou

N I Papachristou

C D Scopa

H Papadaki

H P Kalofonos

D J Papachristou

Affiliations

Soon will be listed here.

Abstract

Purpose: MicroRNAs are evolutionarily conserved non-coding components of the transcriptome that can post-transcriptionally control gene expression. Altered microRNA expression has been found to be a common feature of several cancers, including lung carcinomas. The biogenesis and maturation of microRNAs is known to be mediated by the ribonucleases Drosha, Dicer and Ago2. The purpose of the present study was to investigate the expression and distribution of Drosha, Dicer and Ago2 in human non-small cell lung carcinomas (NSCLC) and to relate the respective expression patterns to clinocopatholical features.

Methods: We used five human NSCLC-derived cell lines and primary formalin-fixed paraffin-embedded tissue samples from 83 NSCLC patients. Drosha, Dicer and Ago2 mRNA and protein expression levels, and their sub-cellular distributions, were assessed using RT-PCR, Western blotting, immunofluorescence and immunohistochemistry, respectively.

Results: We found that Drosha, Dicer and Ago2 were expressed in all the cell lines and primary neoplastic and non-neoplastic tissue samples tested. The intensity of the immunohistochemical staining was found to be significantly lower in stage I tumors compared to normal lung tissues. Dicer expression was found to be significantly higher in stage II compared to stage I tumors, and in stage III compared to stage II and stage I tumors.

Conclusions: Our results point at a role of Drosha, Dicer and Ago2 in the development of NSCLC and suggest that Dicer may be implicated in the progression of these tumors to advanced stages.

Citing Articles

Variant Analysis of miRNA Regulatory Genes in 35 Sporadic Lung Carcinoma Tumors.

Bagci O, Ozdemir E, Sanliturk B Dokl Biochem Biophys. 2024; 513(Suppl 1):S1-S7.

PMID: 38472669 DOI: 10.1134/S1607672924600052.

Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review).

Han P, Zhou J, Xiang J, Liu Q, Sun K Oncol Rep. 2022; 49(1).

PMID: 36367180 PMC: 9685221. DOI: 10.3892/or.2022.8440.

HIF-1α-mediated augmentation of miRNA-18b-5p facilitates proliferation and metastasis in osteosarcoma through attenuation PHF2.

Luo P, Zhang Y, He F, Tong C, Liu K, Liu H Sci Rep. 2022; 12(1):10398.

PMID: 35729160 PMC: 9213540. DOI: 10.1038/s41598-022-13660-w.

Mechanism underlying the effect of Liujunzi decoction on advanced-stage non-small cell lung cancer in patients after first-line chemotherapy.

Xin X, Wang G, Han R, Jiang Y, Liu C, Liu L J Tradit Chin Med. 2022; 42(1):108-115.

PMID: 35294130 PMC: 10164627.

Methylation of and as a Biomarker for the Detection of Lung Cancer.

Szczyrek M, Grenda A, Kuznar-Kaminska B, Krawczyk P, Sawicki M, Batura-Gabryel H Cancers (Basel). 2021; 13(23).

PMID: 34885248 PMC: 8657200. DOI: 10.3390/cancers13236139.

References

Potenza N, Papa U, Russo A . Differential expression of Dicer and Argonaute genes during the differentiation of human neuroblastoma cells. Cell Biol Int. 2009; 33(7):734-8. DOI: 10.1016/j.cellbi.2009.04.002. View

Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

Merritt W, Lin Y, Han L, Kamat A, Spannuth W, Schmandt R . Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med. 2008; 359(25):2641-50. PMC: 2710981. DOI: 10.1056/NEJMoa0803785. View

Tomankova T, Petrek M, Kriegova E . Involvement of microRNAs in physiological and pathological processes in the lung. Respir Res. 2010; 11:159. PMC: 3001429. DOI: 10.1186/1465-9921-11-159. View

Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K . Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005; 96(2):111-5. PMC: 11158408. DOI: 10.1111/j.1349-7006.2005.00015.x. View

Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J . The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003; 425(6956):415-9. DOI: 10.1038/nature01957. View

Diaz-Garcia C, Agudo-Lopez A, Perez C, Lopez-Martin J, Rodriguez-Peralto J, de Castro J . DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification. Carcinogenesis. 2013; 34(5):1031-8. DOI: 10.1093/carcin/bgt022. View

Chen C, Chen H, Sun J, Bringas Jr P, Chen Y, Warburton D . Smad1 expression and function during mouse embryonic lung branching morphogenesis. Am J Physiol Lung Cell Mol Physiol. 2005; 288(6):L1033-9. DOI: 10.1152/ajplung.00277.2004. View

Ahn S, Jeong E, Lee T, Kim S, Kim H, Kim C . Gefitinib induces cytoplasmic translocation of the CDK inhibitor p27 and its binding to a cleaved intermediate of caspase 8 in non-small cell lung cancer cells. Cell Oncol (Dordr). 2014; 37(5):377-86. DOI: 10.1007/s13402-014-0198-0. View

10.

Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

11.

Zhang J, Fan X, Wang C, Liu B, Li Q, Zhou X . Up-regulation of Ago2 expression in gastric carcinoma. Med Oncol. 2013; 30(3):628. DOI: 10.1007/s12032-013-0628-2. View

12.

Papachristou D, Korpetinou A, Giannopoulou E, Antonacopoulou A, Papadaki H, Grivas P . Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch. 2011; 459(4):431-40. DOI: 10.1007/s00428-011-1119-5. View

13.

Farazi T, Spitzer J, Morozov P, Tuschl T . miRNAs in human cancer. J Pathol. 2010; 223(2):102-15. PMC: 3069496. DOI: 10.1002/path.2806. View

14.

Lund E, Guttinger S, Calado A, Dahlberg J, Kutay U . Nuclear export of microRNA precursors. Science. 2003; 303(5654):95-8. DOI: 10.1126/science.1090599. View

15.

Williams A, Moschos S, Perry M, Barnes P, Lindsay M . Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn. 2006; 236(2):572-80. PMC: 2582151. DOI: 10.1002/dvdy.21047. View

16.

Lim L, Lau N, Garrett-Engele P, Grimson A, Schelter J, Castle J . Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005; 433(7027):769-73. DOI: 10.1038/nature03315. View

17.

Frank D, Abtahi A, Yamaguchi D, Manning S, Shyr Y, Pozzi A . Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension. Circ Res. 2005; 97(5):496-504. DOI: 10.1161/01.RES.0000181152.65534.07. View

18.

Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

19.

Sugito N, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Kurehara H . RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res. 2006; 12(24):7322-8. DOI: 10.1158/1078-0432.CCR-06-0515. View

20.

Bjaanaes M, Halvorsen A, Solberg S, Jorgensen L, Dragani T, Galvan A . Unique microRNA-profiles in EGFR-mutated lung adenocarcinomas. Int J Cancer. 2014; 135(8):1812-21. PMC: 4235315. DOI: 10.1002/ijc.28828. View